An announcement from LivaNova PLC (LIVN) is now available.
In a strategic shift to bolster its core businesses, a company has overhauled its operational structure by phasing out its Advanced Circulatory Support division and integrating its products into the Cardiopulmonary segment. This consolidation simplifies the company’s reporting from three to two segments, aiming to sharpen the focus on Cardiopulmonary and Neuromodulation. To assist investors, the company has recast historical financial data to reflect the new segment organization, ensuring transparent comparability without altering past consolidated financial outcomes.
See more insights into LIVN stock on TipRanks’ Stock Analysis page.
